Literature DB >> 27175124

Isolation, characterization and therapeutic potential assessment of bacteriophages virulent to Staphylococcus aureus associated with goat mastitis.

A K Mishra1, N Sharma1, A Kumar1, N Kumar4, M R Gundallahalli Bayyappa2, S Kumar3, N Kumar4.   

Abstract

In the present study, the therapeutic potential of bacteriophages virulent to Staphylococcus aureus associated with goat mastitis were isolated, identified and assessed. Staphylococcus aureus (host or indicator bacterium) was isolated from a goat suffering from clinical mastitis. Based on cultural, morphological, biochemical tests and amplification of S. aureus specific thermonuclease gene in PCR, the identity of the organism was confirmed as S. aureus. Bacteriophages were isolated from soil and faecal samples (n=42) collected from different parts of the Mathura district in Uttar Pradesh (India), and their identity was confirmed by amplification of the bacteriophage-specific endolysin gene fragment in PCR. The thermal tolerance study revealed that all phage isolates were stable at 30 and 40°C with 100% lytic efficacy and their activities reduced to 62-80% at 50°C declining sharply at 60°C with less than 5% efficacy. Likewise, at pH = 6.5 and 7.5, the survivability of all isolates was 100% which reduced to 70-79% and 84-91% at pH = 5.5 and 8.5, respectively. All isolates were stable up to 3 months at 37°C, and for 16 months at 4°C but the stability of their respective endolysins only lasted for 12-23 days at 37°C and 6 months at 4°C. Three of the bacteriophage isolates, S. aureus phage/CIRG/1, S. aureus phage/CIRG/4 and S. aureus phage/CIRG/5 exhibited lytic activity against over 80% of the staphylococcal isolates. The results of the present study provide insight for the use of lytic bacteriophages for therapeutic interventions against multi-drug-resistant S. aureus inducing mastitis in goats.

Entities:  

Keywords:  Bacteriophage; Endolysin; Goat; Mastitis; Staphylococcus aureus

Year:  2014        PMID: 27175124      PMCID: PMC4789206     

Source DB:  PubMed          Journal:  Iran J Vet Res        ISSN: 2252-0589            Impact factor:   1.376


  26 in total

Review 1.  Biofilm, city of microbes.

Authors:  P Watnick; R Kolter
Journal:  J Bacteriol       Date:  2000-05       Impact factor: 3.490

Review 2.  The potential of phages to prevent MRSA infections.

Authors:  Nicholas H Mann
Journal:  Res Microbiol       Date:  2008-04-26       Impact factor: 3.992

3.  Efficacy of bacteriophage therapy in a model of Burkholderia cenocepacia pulmonary infection.

Authors:  Lisa A Carmody; Jason J Gill; Elizabeth J Summer; Uma S Sajjan; Carlos F Gonzalez; Ryland F Young; John J LiPuma
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

4.  Isolation and Partial Characterization of Two Aeromonas hydrophila Bacteriophages.

Authors:  M S Chow; M A Rouf
Journal:  Appl Environ Microbiol       Date:  1983-05       Impact factor: 4.792

5.  Staphylococcal bacteriophage-associated lysin: a lytic agent active against Staphylococcus aureus.

Authors:  S A Sonstein; J M Hammel; A Bondi
Journal:  J Bacteriol       Date:  1971-08       Impact factor: 3.490

6.  Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium.

Authors:  Biswajit Biswas; Sankar Adhya; Paul Washart; Brian Paul; Andrei N Trostel; Bradford Powell; Richard Carlton; Carl R Merril
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

Review 7.  Bacteriophage endolysins as a novel class of antibacterial agents.

Authors:  Jan Borysowski; Beata Weber-Dabrowska; Andrzej Górski
Journal:  Exp Biol Med (Maywood)       Date:  2006-04

Review 8.  Treatment of Staphylococcus aureus infections: new issues, emerging therapies and future directions.

Authors:  Emma J Bishop; Benjamin P Howden
Journal:  Expert Opin Emerg Drugs       Date:  2007-03       Impact factor: 4.191

9.  Evidence to support the therapeutic potential of bacteriophage Kpn5 in burn wound infection caused by Klebsiella pneumoniae in BALB/c mice.

Authors:  Seema Kumari; Kusum Harjai; Sanjay Chhibber
Journal:  J Microbiol Biotechnol       Date:  2010-05       Impact factor: 2.351

10.  Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11.

Authors:  Shigenobu Matsuzaki; Masaharu Yasuda; Hiroshi Nishikawa; Masayuki Kuroda; Takako Ujihara; Taro Shuin; Yuan Shen; Zhe Jin; Shigeyoshi Fujimoto; M D Nasimuzzaman; Hiroshi Wakiguchi; Shigeyoshi Sugihara; Tetsuro Sugiura; Shigeki Koda; Asako Muraoka; Shosuke Imai
Journal:  J Infect Dis       Date:  2003-02-07       Impact factor: 5.226

View more
  4 in total

1.  TSP, a virulent Podovirus, can control the growth of Staphylococcus aureus for 12 h.

Authors:  Rabia Tabassum; Abdul Basit; Iqbal Ahmed Alvi; Muhammad Asif; Shafiq Ur Rehman
Journal:  Sci Rep       Date:  2022-06-15       Impact factor: 4.996

2.  Susceptibility of caprine mastitis pathogens to tildipirosin, gamithromycin, oxytetracycline, and danofloxacin: effect of serum on the in vitro potency of current macrolides.

Authors:  Juan Sebastian Galecio; Elisa Escudero; Juan Carlos Corrales; Edgar García-Romero; Christian de la Fe; Verónica Hernandis; Pedro Marin
Journal:  World J Microbiol Biotechnol       Date:  2022-09-13       Impact factor: 4.253

3.  Prevalence and bacterial etiology of subclinical mastitis in goats reared in organized farms.

Authors:  A K Mishra; Nitika Sharma; D D Singh; K Gururaj; Vijay Kumar; D K Sharma
Journal:  Vet World       Date:  2018-01-13

4.  Bacillus phage endolysin, lys46, bactericidal properties against Gram-negative bacteria.

Authors:  Mohammad Reza Sarjoughian; Fereshte Rahmani; Shamsozoha Abolmaali; Shakiba Darvish Alipour Astaneh
Journal:  Iran J Microbiol       Date:  2020-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.